Scalper1 News
Salix Pharmaceuticals missed third-quarter earnings and sales forecasts and announced the sudden resignation of its chief financial officer, sending shares plunging late Thursday. Earlier, Akorn (AKRX) stock sold off on its messy Q3 results, but investors viewed its issues as mild, relatively, compared with its midsize pharma peer. Salix Pharmaceuticals (SLXP) reported after the close that earnings excluding one-time items rose 72% Scalper1 News
Scalper1 News